OraSure Technologies Receivables 2010-2024 | OSUR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

OraSure Technologies receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

OraSure Technologies receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$203.4B
Stryker (SYK)	$148.7B
Boston Scientific (BSX)	$134.9B
EssilorLuxottica (ESLOY)	$111.5B
Medtronic (MDT)	$108.7B
Haleon (HLN)	$43.2B
Lonza Group Ag (LZAGY)	$42.4B
GE HealthCare Technologies (GEHC)	$37.5B
ResMed (RMD)	$35.8B
Terumo (TRUMY)	$29.4B
Koninklijke Philips (PHG)	$24.8B
Zimmer Biomet Holdings (ZBH)	$21.6B
Insulet (PODD)	$18.4B
Baxter (BAX)	$16.8B
Smith & Nephew SNATS (SNN)	$10.9B
BellRing Brands (BRBR)	$9.9B
Bio-Rad Laboratories (BIO)	$9.1B
Demant (WILYY)	$8.3B
Lantheus Holdings (LNTH)	$6.1B
TG Therapeutics (TGTX)	$5.4B
Haemonetics (HAE)	$4.3B
Prestige Consumer Healthcare (PBH)	$4.2B
ICU Medical (ICUI)	$4.1B
Perrigo (PRGO)	$3.7B
Envista Holdings (NVST)	$3.7B
Agios Pharmaceuticals (AGIO)	$3.2B
Neogen (NEOG)	$3.2B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$2.8B
QuidelOrtho (QDEL)	$2.5B